Phosphoprotein-based Biomarkers as Predictors for Cancer Therapy
Angela M. Carter(University of Alabama at Birmingham), James Bibb(University of Arizona)
Cited by 0
Related Papers
Memory Enhancement by Targeting Cdk5 Regulation of NR2B
|Neuron|2014|133
Systemic Administration of a Brain Permeable Cdk5 Inhibitor Alters Neurobehavior
|Frontiers in Pharmacology|2022|22
Genetic impairment of succinate metabolism disrupts bioenergetic sensing in adrenal neuroendocrine cancer
|Cell Reports|2022|16
Cdk5 mediates rotational force-induced brain injury
|Scientific Reports|2023|11
Cdk5 drives formation of heterogeneous pancreatic neuroendocrine tumors
|bioRxiv (Cold Spring Harbor Laboratory)|2021|7